Sukamoto Takayuki | Department Of Pharmacology Jichi Medical School
スポンサーリンク
概要
関連著者
-
Sukamoto Takayuki
Department Of Pharmacology Jichi Medical School
-
Hara Hideaki
Department Of Biofunctional Evaluation Molecular Pharmacology Gifu Pharmaceutical University
-
Morimoto Yasuo
Department Of Chemical Engineering Osaka Prefecture University
-
Oshima Shinya
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
SHIMOHARA Koichi
Department of Applied Pharmacology, Kyoto Pharmaceutical University
-
Hara Hideaki
参天製薬
-
Yokota Koichi
Department Of Dermatology Hakodate Central General Hospital
-
Iwamoto Takahiro
Department Of Medical Engineering And Cardiology Institute Of Development Aging And Cancer Tohoku Un
-
WATANO Tomokazu
Department of Pharmacology, Fukushima Medical University, School of Medicine
-
SOKABE HIROFUMI
Department of Pharmacology, Jichi Medical School
-
Watano Tomokazu
Department Of Pharmacology Fukushima Medical University School Of Medicine
-
Ito Keizo
Department Of Hygiene And Preventive Medicine School Of Medicine Hokkaido University
-
MORITA Tominori
Department of Biology, New Drug Research Laboratories, Kanebo Ltd.
-
Shiono Kumiko
Department Of Pharmacology Jichi Medical School
-
Sokabe Hirofumi
Department Of Pharmacology Jichi Medical School
-
Sokabe Hirofumi
Department Of Parmacology Toho University Shool Of Medicine
-
Hara Hideaki
Department Of Pharmacology New Drug R & D Laboratory Kanebo Ltd
-
Watanabe Takushi
Department Of Pharmacology Jichi Medical School
-
Shimazawa Masamitsu
Department Of Biofunctional Evaluation Molecular Pharmacology Gifu Pharmaceutical University
-
Tanaka Keiko
Department Of Anesthesiology Akashi Municipal Hospital
-
WATANABE Takushi
Departine rt of Pharmacology, Jichi Medical School
-
SOKABE Hirofumi
Departine rt of Pharmacology, Jichi Medical School
-
Ito Keizo
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
Yokota Koichi
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
Morimoto Yasuo
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
Shimazawa Masamitsu
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
Shimohara Koichi
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
Morimoto Yasuo
Department of Pharmacology, New Drug Research Laboratories, Kanebo, Ltd.
-
Iwamoto Takahiro
Department of Pharmacology, New Drug Research Laboratories, Kanebo Ltd.
-
Sukamoto Takayuki
Department of Pharmacology, New Drug Research Laboratories, Kanebo, Ltd.
著作論文
- Inhibitory Effect of Lomerizine, a Diphenylpiperazine Ca^-Channel Blocker, on Ba^ Current through Voltage-Gated Ca^ Channels in PC12 Cells
- EFFECTS OF β-ADRENERGIC BLOCKING DRUGS IN HYPERTENSIVE RATS
- Effects of KB-5492, a New Anti-Ulcer Agent, on Ethanol- and Acidified Aspirin-Induced Gastric Mucosal Damage In Vivo and In Vitro.
- Effect of KB-2796, a New Diphenylpiperazine Ca2+ Antagonist, on Glutamate-Induced Neurotoxicity in Rat Hippocampal Primary Cell Cultures.
- Effects of KB-2796, a New Diphenylpiperazine Calcium Antagonist, on Renal Hemodynamics and Urine Formation in Anesthetized Dogs.
- Effects of the New Anti-Ulcer Agent KB-5492 on Experimental Gastric Mucosal Lesions and Gastric Mucosal Defensive Factors, as Compared to Those of Teprenone and Cimetidine.
- 4-Methoxyphenyl 4-(3,4,5-Trimethoxybenzyl)-1-Piperazineacetate Monofumarate Monohydrate (KB-5492), a New Anti-Ulcer Agent with a Selective Affinity for the Sigma Receptor, Prevents Cysteamine-Induced Duodenal Ulcers in Rats by a Mechanism Different from T